MEDICLIN (0NDG) Ratios
MEDICLIN Ratios
GB:0NDG's free cash flow for Q2 2026 was $8.53M. For the 2026 fiscal year, GB:0NDG's free cash flow was decreased by $-8.34M and operating cash flow was $16.87M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.62 | 1.79 | 1.75 | 1.53 | 1.25 |
| Quick Ratio | 1.58 | 1.75 | 1.71 | 1.48 | 1.21 |
| Cash Ratio | 0.44 | 0.65 | 0.67 | 0.52 | 0.56 |
| Solvency Ratio | 0.14 | 0.11 | 0.11 | 0.11 | 0.11 |
| Operating Cash Flow Ratio | 0.61 | 0.49 | 0.46 | 0.20 | 0.38 |
| Short-Term Operating Cash Flow Coverage | 3.50 | 43.23 | 2.89 | 1.29 | 3.05 |
| Net Current Asset Value | $ -366.92M | $ -385.58M | $ -384.65M | $ -444.78M | $ -432.28M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.44 | 0.51 | 0.54 | 0.55 | 0.50 |
| Debt-to-Equity Ratio | 1.57 | 2.09 | 2.45 | 2.40 | 2.40 |
| Debt-to-Capital Ratio | 0.61 | 0.68 | 0.71 | 0.71 | 0.71 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.23 | 0.25 | 0.24 | 0.27 |
| Financial Leverage Ratio | 3.53 | 4.07 | 4.49 | 4.38 | 4.81 |
| Debt Service Coverage Ratio | 1.81 | 3.84 | 1.95 | 2.45 | 2.34 |
| Interest Coverage Ratio | 1.85 | 2.23 | 0.53 | 1.84 | 1.24 |
| Debt to Market Cap | 0.24 | 0.58 | 0.73 | 0.55 | 0.52 |
| Interest Debt Per Share | 8.67 | 10.28 | 10.61 | 10.81 | 9.46 |
| Net Debt to EBITDA | 3.23 | 3.35 | 3.60 | 4.52 | 3.75 |
| Profitability Margins | |||||
| Gross Profit Margin | 14.51% | 83.20% | 81.44% | 81.16% | 81.86% |
| EBIT Margin | 4.90% | 7.49% | 2.09% | 2.89% | 1.75% |
| EBITDA Margin | 12.58% | 14.21% | 13.87% | 13.03% | 12.69% |
| Operating Profit Margin | 4.90% | 7.14% | 1.74% | 2.77% | 1.72% |
| Pretax Profit Margin | 4.49% | 4.29% | -1.19% | 1.39% | 0.36% |
| Net Profit Margin | 3.25% | 3.32% | -1.48% | 1.34% | 0.22% |
| Continuous Operations Profit Margin | 3.30% | 3.33% | -1.47% | 1.38% | 0.22% |
| Net Income Per EBT | 72.41% | 77.33% | 124.02% | 96.56% | 59.73% |
| EBT Per EBIT | 91.57% | 60.05% | -68.30% | 50.09% | 21.15% |
| Return on Assets (ROA) | 2.90% | 2.74% | -1.22% | 1.03% | 0.17% |
| Return on Equity (ROE) | 10.24% | 11.16% | -5.50% | 4.51% | 0.80% |
| Return on Capital Employed (ROCE) | 5.36% | 7.23% | 1.79% | 2.62% | 1.73% |
| Return on Invested Capital (ROIC) | 3.80% | 5.40% | 1.55% | 2.44% | 0.94% |
| Return on Tangible Assets | 2.95% | 2.82% | -1.26% | 1.10% | 0.18% |
| Earnings Yield | 14.50% | 21.61% | -8.40% | 5.52% | 0.78% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.31 | 4.17 | 4.76 | 5.04 | 6.04 |
| Payables Turnover | 46.13 | 9.77 | 10.73 | 9.16 | 9.38 |
| Inventory Turnover | 122.98 | 16.41 | 18.57 | 14.97 | 14.34 |
| Fixed Asset Turnover | 1.56 | 1.40 | 1.42 | 1.30 | 1.32 |
| Asset Turnover | 0.89 | 0.83 | 0.83 | 0.77 | 0.76 |
| Working Capital Turnover Ratio | 6.77 | 5.76 | 6.64 | 9.81 | 15.83 |
| Cash Conversion Cycle | 79.71 | 72.41 | 62.33 | 56.92 | 47.00 |
| Days of Sales Outstanding | 84.66 | 87.52 | 76.68 | 72.39 | 60.47 |
| Days of Inventory Outstanding | 2.97 | 22.24 | 19.65 | 24.38 | 25.45 |
| Days of Payables Outstanding | 7.91 | 37.36 | 34.01 | 39.84 | 38.93 |
| Operating Cycle | 87.62 | 109.76 | 96.34 | 96.76 | 85.92 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.10 | 1.70 | 1.64 | 0.73 | 1.73 |
| Free Cash Flow Per Share | 1.08 | 0.76 | 0.85 | 0.18 | 1.37 |
| Dividend Paid and CapEx Coverage Ratio | 1.98 | 1.80 | 2.08 | 1.33 | 4.82 |
| Capital Expenditure Coverage Ratio | 2.06 | 1.80 | 2.08 | 1.33 | 4.82 |
| Operating Cash Flow Coverage Ratio | 0.26 | 0.17 | 0.16 | 0.07 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.11 | 0.11 | 0.05 | 0.12 |
| Free Cash Flow Yield | 29.27% | 31.21% | 31.52% | 5.04% | 34.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 6.85 | 4.65 | -11.90 | 18.11 | 127.45 |
| Price-to-Sales (P/S) Ratio | 0.22 | 0.15 | 0.18 | 0.24 | 0.28 |
| Price-to-Book (P/B) Ratio | 0.71 | 0.52 | 0.65 | 0.82 | 1.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 3.42 | 3.20 | 3.17 | 19.84 | 2.87 |
| Price-to-Operating Cash Flow Ratio | 1.76 | 1.43 | 1.64 | 4.94 | 2.27 |
| Price-to-Earnings Growth (PEG) Ratio | 1.78 | -0.01 | 0.06 | 0.03 | -1.10 |
| Enterprise Value Multiple | 5.01 | 4.43 | 4.87 | 6.38 | 5.93 |
| Enterprise Value | 494.40M | 471.51M | 492.79M | 585.63M | 506.64M |
| EV to EBITDA | 5.01 | 4.43 | 4.87 | 6.38 | 5.93 |
| EV to Sales | 0.63 | 0.63 | 0.67 | 0.83 | 0.75 |
| EV to Free Cash Flow | 9.61 | 13.14 | 12.19 | 67.93 | 7.80 |
| EV to Operating Cash Flow | 4.95 | 5.85 | 6.32 | 16.91 | 6.18 |
| Tangible Book Value Per Share | 4.90 | 4.17 | 3.65 | 3.24 | 2.65 |
| Shareholders’ Equity Per Share | 5.24 | 4.68 | 4.12 | 4.40 | 3.86 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.22 | -0.23 | 0.01 | 0.39 |
| Revenue Per Share | 16.52 | 15.76 | 15.37 | 14.84 | 14.17 |
| Net Income Per Share | 0.54 | 0.52 | -0.23 | 0.20 | 0.03 |
| Tax Burden | 0.72 | 0.77 | 1.24 | 0.97 | 0.60 |
| Interest Burden | 0.92 | 0.57 | -0.57 | 0.48 | 0.21 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.10 | 0.03 | 0.02 | 0.00 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 3.92 | 3.23 | -7.24 | 3.56 | 55.19 |
Currency in EUR
